NCT04657068 2026-03-18A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsArtios Pharma LtdPhase 1/2 Recruiting442 enrolled
NCT06607185 2026-03-13A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT02658214 2020-08-20Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsAstraZenecaPhase 1 Completed32 enrolled
NCT00390182 2020-03-18GCC0319University of Maryland, BaltimorePhase 1/2 Completed38 enrolled 9 charts
NCT01325558 2016-07-15A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsAltor BioSciencePhase 1 Completed30 enrolled